Software Platform for Glycan Quantification and Qualification by LCMS-8060/8050 - Erexim Application Suite

C10G-E054 Solutions for Biopharmaceutical Application Notebook First Edition: December, 2017 © Shimadzu Corporation, 2017 Solutions for Biopharmaceutical Index Application Notebook Bioanalysis LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Trastuzumab analysis nSMOL, which enables selective proteolysis of the…

PO-CON1558E Quantification and structural characterization of glycans and glycopeptides by TQMS: the energy-resolved oxonium ion monitoring (Erexim) platform ASMS 2015 MP686 Atsuhiko Toyama1, Shuuichi Nakaya1, Shinji Funatsu1, Koji Ueda2, Yoshihiro Hayakawa1, Ichiro Hirano1 1 Shimadzu Corporation; 1 Nishinokyo-Kuwabaracho Nakagyo-ku, Kyoto…

Application Note Comprehending COVID-19: Structural Characterization of the Glycan Assemblies of O-linked Glycopeptides Using Cyclic Ion Mobility Lindsay Morrison Waters Corporation, Georgetown University Medical Center, Lombardi Comprehensive Cancer Center For research use only. Not for use in diagnostic procedures. Save…

APPLICATION NOTE 73672 Accelerating monoclonal antibody peptide mapping with high acquisition speed Orbitrap-based MS Authors: Phil Widdowson, Amy Claydon, Tom Buchanan Thermo Fisher Scientific, Hemel Hempstead, UK Keywords: Peptide mapping, monoclonal antibody, mAb, post-translational modification, PTM, high throughput analysis, golimumab,…